Calidi Biotherapeutics, Inc.CLDINYSE
Loading
Gross Profit Growth TrendStable
Percentile Rank29
Year-over-Year Change
Year-over-year gross profit growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P29
Within normal range
Average
-15.80%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | -2.75% |
| Q4 2023 | -264.00% |
| Q3 2023 | 72.53% |
| Q2 2023 | -98.91% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | -100.00% |
| Q1 2022 | -91.27% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |